- Clark ACL, Dudley HAF, Hudson B, et al. An integrated final undergraduate examination. Br J Med Educ 1967; 1: 353-5.
- Potworowski EF, Nairn RC. Specific antigenicity of thymocytes. Nature 1967; 213: 1135-6.
- Potworowski EF, Nairn RC. Origin and fate of a thymocyte-specific antigen. Immunology 1967; 13: 597-602.
- Nairn RC. Oedema and capillary anoxia. J Pathol Bacteriol 1958; 63: 213-34.
- Nairn RC. The effect of reduced renal blood flow on the excretion of sodium chloride and the production of oedema in the rabbit. J Pathol Bacterial 1953; 66: 457-72.
- Nairn RC, Chadwick CS, McEntegart MG. Fluorescent protein tracers in the study of experimental liver damage. J Pathol Bacterial 1958; 76: 143-53.
- McEntegart MG, Chadwick CS, Nairn RC. Fluorescent antisera in the detection of serological varieties of Trichomonas vaginalis. Br J Vener Dis 1958; 34: 1-3.
- Nairn RC, Fraser KB, Chadwick CS. The histological localization of renin with fluorescent antibody. Br J Exp Pathol 1959; 40: 155-63.
- Nairn RC, Richmond HG, McEntegart MG, Fothergill JE. Immunological differences between normal and malignant cells. Br Med J 1960; 2: 1335-40.
- Nairn RC, Fothergill JE, McEntegart MG, Porteous IB. Gastro-intestinal-specific antigen: an immunohistological and serological study. Br Med J 1962; 1: 1788-90.
- Nairn RC, Fothergill JE, McEntegart MG, Richmond HG. Loss of gastrointestinal-specific antigen in neoplasia. Br Med J 1962; 1: 1791-3.
- Nairn RC. Fluorescent Protein Tracing. 1st ed, Edinburgh, E & S Livingston, 1962.
- Nairn RC, Chose T, Tannenberg AEG. Kidney-specific antigen depletion in human renal carcinomas. Br J Cancer 1996; 20: 756-9.
- Muller HK, McGiven AR, Nairn RC. Immunofluorescent staining of rat gastric parietal cells by human antibody unrelated to pernicious anaemia. J Clin Pathol 1971; 24: 13-4.
- Lewis MG, Ikonopisov RL, Nairn RC, et al. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J 1969; 3: 547-52.
- Nairn RC, Hind APP, Guli EPG, et al. Specific immune response in human skin carcinoma. Br Med J 1971; 4: 701-5.
- Nairn RC, Nind APP, Guli EPG, et al. Immunological reactivity in patients with carcinoma of colon. Br Med J 1971; 4: 706-9.
- Flannery GR, Chalmers PJ, Rolland JM, Nairn RC. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy. Br J Cancer 1973; 28: 118-22.
- Nind APP, Nairn RC, Rolland JM, et al. Lymphocyte anergy in patients with carcinoma. Br J Cancer 1973; 28: 108-17.
- Nind APP, Matthews N, Pihl EAV, et al. Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma. Br J Cancer 1975; 31: 620-9.
- Pihl E, Hughes ESR, Nind APP, Nairn RC. Colonie carcinoma: clinicopathological correlation with immunoreactivity. Br Med J 1975; 3: 742-3.
- Pihl E, Nairn RC, Nind AP, et al. Correlation of regional lymph node histology with in vitro antitumor immunoreactivity in colorectal carcinoma. Cancer Res 1976; 36: 3665-71.
- Werkmeister JA, Pihl E, Nind APP, et al. Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma. Br J Cancer 1979; 40: 839-47.
- Nind APP, Nairn RC, Pihl E, et al. Autochthonous humoral and cellular immunoreactivity to colorectal carcinoma: prognostic significance in 400 patients. Cancer Immunol Immunother 1980; 7: 257-61.
- Pihl E, Nairn RC, Milne BJ, et al. Lymphoid hyperplasia: a major prognostic feature in 519 cases of colorectal carcinoma. Am J Pathol 1980; 100: 469-80.
- Nairn RC. Standardization in immunofluorescence. Clin Exp Immunol 1968; 3: 465-76.
- Nairn RC, Rolland JM. Fluorescent probes: a new way to study lymphocyte activation. Endeavour 1981; 5: 167-71.
- Martin CL, Rolland JM, Nairn RC, Muller HK. Selection of optical filters for laser flow cytometry using fluorescent conjugates. Cytometry 1982; 2: 374-82.
- Nairn RC. Lymphocyte activation studies by fluorescent probes. Ann NY Acad Sci 1984; 420: 208-14.
- Rolland JM, Hocking GR, Nairn RC. Fluorescent lymphocyte probes for cancer detection. Ann NY Acad Sci 1984; 420: 215-8.
- Nairn RC. Place of immunotherapy in treatment of cancer. Patient Manage 1977; 6: 57-64.
- Nairn J. Come in Billy Nairn. Western Australia: North Stirling Press, 1980.
RICHARD CHARLES NAIRN, FOUNDATION PROFESSOR OF PATHOLOGY AND IMMUNOLOGY AT MONASH UNIVERSITY
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.